Clinical trial
A Combination of L-Arabinose and Chromium Lowers Circulating Glucose and Insulin Levels After Acute Oral Sucrose Challenge
NCT01107431 is registered in ClinicalTrials.gov with Integrative Health Technologies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Combination of L-Arabinose and Chromium Lowers Circulating Glucose and Insulin Levels After Acute Oral Sucrose Challenge
- Lead sponsor
- Integrative Health Technologies, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- December 31, 2009
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pre-diabetes